We are live on ! Find out more
RADX

Radiopharm Theranostics
RADX

7 hedge funds and large institutions have $2.06M invested in Radiopharm Theranostics in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$562

Top Sellers

1
-$637K
2
-$248K
3
-$76K
4
Jane Street
Jane Street
New York
-$75.5K
5
UBS Group
UBS Group
Switzerland
-$55.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Silverarc Capital Management
Massachusetts
$806K
SCM
2
Stonepine Capital Management
Oregon
$739K
HSBC Holdings
3
HSBC Holdings
United Kingdom
$265K
RP
4
Regal Partners
Australia
$173K
PNC Financial Services Group
5
PNC Financial Services Group
Pennsylvania
$68.8K
UBS Group
6
UBS Group
Switzerland
$12.9K
RhumbLine Advisers
7
RhumbLine Advisers
Massachusetts
$519
VF
8
Virtu Financial
New York
–
Jane Street
9
Jane Street
New York
–
MG
10
Marex Group
–
SWP
11
Strategic Wealth Partners
Ohio
–